Zegruvirimat

N/A

Report date: 2025/06/26 16:55:05
NME

Base Information

Drug NameZegruvirimat
Drug Alias NameGSK3739937GSK-3739937VH-3739937VH3739937VH-937
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV replication inhibitorsHIV-1 maturation inhibitor
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesViiv HealthcareGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViiv Healthcare
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A